---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-040622"
form_type: "8-K"
ticker: "SHPH"
cik: "0001757499"
company_name: "Shuttle Pharmaceuticals Holdings, Inc."
filed_at: "2026-08-28T20:45:18+00:00"
generated_at: "2026-08-28T20:46:05.653862+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Shuttle Pharmaceuticals receives Nasdaq delisting notice for late Q2 Form 10-Q

## Summary
- Nasdaq notice received Aug 28, 2026 for non-compliance with Listing Rule 5250(c)(1) due to delayed Form 10-Q for quarter ended June 30, 2026.
- Company must submit compliance plan by Oct 27, 2026; Nasdaq may grant exception until Feb 22, 2027.
- No immediate delisting; non-compliance indicator broadcast starting approx. Sept 4, 2026.
- Failure to regain compliance would subject common stock to delisting from Nasdaq; stock continues trading on Nasdaq.
- Company intends to file Form 10-Q as soon as practicable; cites completion of accounting firm review procedures as a factor.

## SEC filing metadata
- accession: 0001493152-26-040622
- form_type: 8-K
- ticker: SHPH
- cik: 0001757499
- company_name: Shuttle Pharmaceuticals Holdings, Inc.
- filed_at: 2026-08-28T20:45:18+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757499/000149315226040622/0001493152-26-040622-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757499/000149315226040622/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-040622
- JSON: https://secwatch.observer/filing/0001493152-26-040622.json
- Plain text: https://secwatch.observer/filing/0001493152-26-040622.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.